Ticker Details
NewAmsterdam Pharma Company
IPO Date:	February 9, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$4.2B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.64 | 3.21%
Avg Daily Range (30 D):	$0.78 | 2.40%
Avg Daily Range (90 D):	$1.02 | 3.14%

Institutional Daily Volume
Avg Daily Volume:	.32M
Avg Daily Volume (30 D):	1M
Avg Daily Volume (90 D):	1.02M

Trade Size
Avg Trade Size (Sh.):	86
Avg Trade Size (Sh.) (30 D):	73
Avg Trade Size (Sh.) (90 D):	79

Institutional Trades
Total Institutional Trades:	1,422
Avg Institutional Trade:	$1.7M
Avg Institutional Trade (30 D):	$3.07M
Avg Institutional Trade (90 D):	$2.12M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$1.87M
Avg Closing Trade (30 D):	$3.17M
Avg Closing Trade (90 D):	$2.67M
Avg Closing Volume:	65.84K

News

Jun 3, 2026 @ 12:00 PM NewAmsterdam Pharma Announces Upcoming Presentatio... Source: Newamsterdam Pharma Company N.V.

May 28, 2026 @ 12:00 PM NewAmsterdam Pharma to Participate at Upcoming Inv... Source: Newamsterdam Pharma Company N.V.

May 1, 2026 @ 8:57 PM NewAmsterdam Pharma Reports Inducement Grants Unde... Source: Na

Apr 2, 2026 @ 9:43 PM NewAmsterdam Pharma Reports Inducement Grants Unde... Source: Newamsterdam Pharma Company N.V.

Feb 4, 2026 @ 1:00 PM NewAmsterdam Pharma to Present at the Guggenheim E... Source: Newamsterdam Pharma Company N.V.

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-1.79	$-.4	$-.63
Diluted EPS	$-1.79	$-.4	$-.63
Revenue	$22.57M	$3.04M	$.03M
Gross Profit
Net Income / Loss	$-212.73M	$-48.44M	$-74.92M
Operating Income / Loss	$-215.18M	$-58.42M	$-65.98M
Cost of Revenue
Net Cash Flow	$-297.13M	$-31.05M	$-48.33M
PE Ratio